stability and packaging
Understanding Stability in Medicines
Definition of Stability:
Relative concept depending on:
Inherent stability of the active pharmaceutical ingredient (API)
Stability of excipients
Dosage form structure
Protectiveness of container closure system
Recommended storage conditions
Sources: Aulton & Taylor, Pharmaceutics 5th edition
Factors Influencing Stability:
API: Characteristic stability
Excipients: Functionality in formulations
Processing: Techniques impacting drug formulation
Packaging: Container material properties
Storage Conditions: Environmental factors affecting stability
Types of Chemical Instability
Oxidation: Breakdown due to reactions with oxygen
Hydrolysis: Breakdown due to reactions with water
Photodegradation: Decomposition due to light exposure
Isomerisation/Polymerisation: Structural rearrangement and combining molecules
Formation of Adducts and Complexes: Unintended connections affecting efficacy
Polymorphic Changes: Transition between different forms affecting solubility
Types of Physical Instability
Suspension Redispersibility/Resuspension: Stability issues in liquid forms
Appearance and Dissolution: Visual characteristics affecting acceptability
Precipitation and Particle Size: Solid phase separation impacting dosage uniformity
Rheology: Flow properties affecting dosage form
Water Content: Moisture levels affecting solubility and stability
Other Instabilities Related to Packaging
Adsorption: Components adhering to package interior
Absorption: Materials being absorbed from the package
Leaching: Leaching of package materials into the product
Microbiological Issues: Contamination risks if not properly preserved
Assessing Stability During Development
Preformulation Studies: Initial assessments of active stability
Stress Testing: Assessing under extreme conditions to identify degradation paths
Formulation Development: Creation of optimal drug combinations for increased stability
Post-Authorization Studies: Long-term stability monitoring after market release
Guidelines for Stability Testing
International guidelines (ICH):
Q1A (R2): Stability testing of New Drug substances and products
Q1B: Photostability Testing
Q1C: Stability Testing for New Dosage Forms
Q1E: Evaluation of Stability Data
Q5C: Stability Testing of Biotechnological/Biological Products
Creating Expiry Dates
Shelf-life Requirements: Must contain ≥ 95% of label claim at expiry
Overages: Limited ability to account for degradation in formulations
Temperature Stability Data: Transformed using the Arrhenius Equation to anticipate shelf life
Reasons for Packaging Medicinal Products
Product Identity: Ensuring the right product is delivered
Protection: Shielding from environmental factors
Patient Compliance: Ease of use and accessibility
Presentation: Clear information and instructions for use
Tamper Protection: Ensuring consumer safety
Types of Primary and Secondary Packaging
Primary Packaging: Directly contains the drug
Examples: Bottles (glass, plastic), tubes, jars
Material Types: Glass (moisture resistance), metal (light protection), plastics (flexibility)
Secondary Packaging: Outer cartons for protection during transport
Includes patient information leaflets and additional labeling.
Sealing and Filling Methods
Sealing Techniques: Screw caps, push-on lids, heat seals for ampoules
Filling Methods:
Volumetric Filling: Using pumps or cylinders
Weigh Filling: Ensuring accurate dosing by weight
Integrity Testing and Common Problems
Integrity Testing: Regular checks during the manufacturing process for leaks or contamination
Common Issues:
Banana shaping due to material stress
Distortion in blisters leading to product damage
Labelling: Methods and Types
Variable Data Printing: Batch numbers, expiry dates
Labelling Methods: Roll-on, pick-and-place for precise application
Types of Labels: Partial or total wraparound, panel labels for larger containers therefore ensuring thorough information transfer to consumers.
Quality Assessment in Packaging
Ensuring compliance with quality control measures including:
Labeling accuracy
Sterility in sterile products
Correct quantity and absence of particulates or damage
Continuous monitoring of the packaging process to ensure a high standard at all times.